Search for a trial

Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of;Aztreonam 75 mg Powder and Solvent for Nebuliser;Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric;Patients with Cystic Fibrosis (CF) and New Onset Lower Respiratory;Tract Culture Positive for Pseudomonas aeruginosa (PA)

The purpose of this study is to evaluate whether aztreonam solution for inhalation (AZLI) is safe and effective for the treatment and complete eradication of a lung infection with PA (Pseudomonas aeruginosa) in patients with Cystic Fibrosis (CF) and…